ABELZETA
LIVE

Serial Number

98098345

Owner

ABELZETA INC.

Attorney

Lauren Beth Emerson

Filing Date

Jul 24, 2023

Add to watchlist:

No watchlists yet
View on USPTO

ABELZETA Trademark

Serial Number: 98098345

ABELZETA is a trademark filed by ABELZETA INC. on July 24, 2023. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

ABELZETA INC. (6 trademarks)

9605 MEDICAL CENTER DRIVE, SUITE 100
ROCKVILLE, MD 20850

Entity Type: 03

CELLULAR BIOMEDICINE GROUP, INC. (6 trademarks)

9605 MEDICAL CENTER DRIVE, SUITE 100
ROCKVILLE, MD 20850

Entity Type: 03

Trademark Details

Filing Date

July 24, 2023

Registration Date

Not Registered

Published for Opposition

May 7, 2024

Goods & Services

Excipients for use in the manufacture of pharmaceutical and biological preparations for research and medical use; viral vectors and plasmids for scientific research

Cell therapy services, namely, immune cell therapy services and medical treatment using cultured cells; Collection and preservation of biological tissue, blood and cells; providing medical information; providing health information in the field of oncology; providing medical information in the field of pharmaceuticals and cell therapy; medical treatment services, namely, medical treatment of cancer, autoimmune, and inflammatory diseases; medical diagnostic services

Custom manufacturing of biological tissue, blood, and cells; custom manufacturing of pharmaceutical preparations for immunotherapy; custom manufacture of pharmaceutical and biological preparations for medical use, namely, for the prevention and treatment of cancer and autoimmune diseases; custom manufacture of viral vectors and plasmids for research and clinical use; custom manufacture of excipients for use in the manufacture of pharmaceutical and biological preparations for research and medical use

Pharmaceutical and biological preparations for medical use, namely, for the treatment and prevention of diseases, namely, cancer and autoimmune diseases; pharmaceutical preparations, namely, pharmaceutical preparations for use in the treatment of cancer; pharmaceutical and biological preparations for immunotherapy; pharmaceutical and biological preparations for medical diagnostic use; diagnostic kits consisting primarily of cells for medical or clinical use; viral vectors and plasmids for clinical use; cells for medical use

Filing History

SOU TEAS EXTENSION RECEIVED
Jun 24, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 12, 2025 EXRA
SOU EXTENSION 3 GRANTED
Dec 12, 2025 EX3G
SOU EXTENSION 3 FILED
Dec 10, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
Dec 10, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 26, 2025 EXRA
CORRECTED NOA E-MAILED
Nov 25, 2025 NOAC
SOU EXTENSION 2 GRANTED
Nov 25, 2025 EX2G
DIVISIONAL PROCESSING COMPLETE
Nov 25, 2025 DPCC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Nov 24, 2025 AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Nov 24, 2025 AITU
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 23, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 23, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 23, 2025 REAP
DIVISIONAL REQUEST RECEIVED
Jun 3, 2025 DRRR
TEAS REQUEST TO DIVIDE RECEIVED
Jun 3, 2025 ERTD
SOU TEAS EXTENSION RECEIVED
Jun 3, 2025 EEXT
SOU EXTENSION 2 FILED
Jun 2, 2025 EXT2
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 15, 2024 EXRA
SOU EXTENSION 1 GRANTED
Jul 15, 2024 EX1G
SOU EXTENSION 1 FILED
Jul 15, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Jul 15, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 2, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 7, 2024 NPUB
PUBLISHED FOR OPPOSITION
May 7, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 17, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 29, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 29, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 29, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 29, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 29, 2024 CNEA
ASSIGNED TO EXAMINER
Mar 26, 2024 DOCK
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Jan 19, 2024 AMPX
ASSIGNED TO LIE
Jan 19, 2024 ALIE
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Dec 27, 2023 ASGN
TEAS VOLUNTARY AMENDMENT RECEIVED
Aug 28, 2023 PARI
NOTICE OF DESIGN SEARCH CODE E-MAILED
Aug 23, 2023 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 22, 2023 NWOS
NEW APPLICATION ENTERED
Jul 27, 2023 NWAP